LONDON, Jan 16 (Reuters) – Britain said on Monday it will carry out tests on the Jeep Grand Cherokee model following U.S. accusations carmaker Fiat Chrysler Automobiles mislead regulators on diesel… Source
Last week saw many notable developments in the telecom industry U S national wireless carrier T Mobile US Inc TMUS has allowed us a sneak peek into its fourth quarter 2016 results prior to the scheduled release In the quarter the company added 2 1 million net customers taking the...
Shares of two prominent steel producers AK Steel AKS and United States Steel X plummeted on Thursday after a key analyst downgrade AK Steel was down more than 10 4 in early afternoon trading while US Steel dropped more than 6 3 Both of these companies were hampered by a downgrade...
The new MacBook Pro appears to have only slightly helped Apple s Mac unit shipments Image source Apple The iPhone wasn t the only Apple NASDAQ AAPL product to stall in 2016 The Mac has certainly seen better days too and the Mac maker lost global PC market share Source
Image source TransCanada Corporation TransCanada NYSE TRP is a dividend champion in the energy sector Not only has it increased the payout for the past 16 years but it has delivered 7 compound annual dividend growth during that period However its best dividend Source
Lowe s Companies Inc LOW has been appearing bearish for quite some time now This Zacks Rank 4 Sell company has been disappointing investors with its lower than expected top and bottom line results since the past two quarters In the second and third quarters of fiscal 2016 the Source
With earnings season now under way investors can expect to start seeing stocks make some big moves Two names reporting earnings next week that could move big include Netflix NASDAQ NFLX and Interactive Brokers NASDAQ IBKR Raising the stakes ahead of these Source
Mark Twain and an experimental human growth hormone Opko Health NASDAQ OPK executive vice president Steve Rubin managed to combine this unlikely pair at the J P Morgan Healthcare Conference on Wednesday Rubin talked about the recent clinical failure of a human Source